Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1))

Synonyms: Anti-alpha5beta1 integrin monoclonal antibody

Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1)) is a monoclonal antibody targeting Integrin a5b1 (ITGA5 & ITGB1). It can be used in treatment of solid tumors, renal cell carcinoma, melanoma, pancreatic cancer, lung cancer, and ovarian cancer. MW :145.52 KD.

Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1))

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 9.96mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective Integrin Inhibitors

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1)) is a monoclonal antibody targeting Integrin a5b1 (ITGA5 & ITGB1). It can be used in treatment of solid tumors, renal cell carcinoma, melanoma, pancreatic cancer, lung cancer, and ovarian cancer. MW :145.52 KD.

Product Details

CAS No. 558480-40-3
Isotype Human IgG4SP
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1)) | Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1)) supplier | purchase Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1)) | Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1)) cost | Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1)) manufacturer | order Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1)) | Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1)) distributor